Jeffrey Johnson is a legal writer with a focus on personal injury. He has worked on personal injury and sovereign immunity litigation in addition to experience in family, estate, and criminal law. He earned a J.D. from the University of Baltimore and has worked in legal offices and non-profits in Maryland, Texas, and North Carolina. He has also earned an MFA in screenwriting from Chapman Univer...

Full Bio →

Written by

UPDATED: Feb 5, 2020

Advertiser Disclosure

It’s all about you. We want to help you make the right legal decisions.

We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.

Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.

Avandia, GlaxoSmithKline’s (GSK) widely prescribed oral diabetes drug, has been identified as a possible cause of heart attacks and other heart problems in patients with diabetes, stirring up a storm of controversy about the FDA ‘s (Food and Drug Administration) practices in approving drugs and monitoring drug safety.

A new study containing a meta-analysis of previous studies of Avandia was published in the online version of the New England Journal of Medicine (NEJM) on May 21, 2007. The analysis showed that Avandia created a significant risk of increased heart attacks and other heart problems in patients with diabetes.

The study produced predicted results, and lawsuits for serious personal injury and wrongful death cause by taking Avandia began to be filed in 2007. For example, the family of a nurse who required 3 bypass operations and finally died of a stroke, filed suit against GSK. The family claimed that GSK had information about the dangers of Avandia that it withheld.

One of the primary issues in Avandia litigation will be whether the manufacturer, GSK, responsibly reported all the dangers of Avandia to the FDA and to the public. A few U.S. legislators have already raised concerns about GSK’s honesty in this area. GSK has a bad record on safety reporting; it settled a lawsuit filed by then New York Attorney General, and now New York Governor, Eliot Spitzer, in which Spitzer charged GSK with fraudulently withholding results about the safety of prescribing the antidepressant Paxil to children. Part of that settlement was the agreement that GSK would set up the website that the NEJM authors used to obtain much of their data.

GSK claims that the results of its long-term clinical trials contradict the findings of the meta-analysis published in the NEJM.

If you or a loved one has been injured by taking Avandia, you need to have your case reviewed by a lawyer experienced in drug litigation as soon as you can. See Avandia Attorney and Lawyer – How to Hire to find an Avandia expert who will be able help you. Check out the following articles for more information about Avandia, filing an Avandia lawsuit and finding an Avandia attorney.